Repligen
RGEN
#1859
Rank
$11.09 B
Marketcap
$173.49
Share price
2.97%
Change (1 day)
19.11%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2023 (TTM): $2.09

According to Repligen 's latest financial reports the company's current EPS (TTM) is -$0.20. In 2022 the company made an earnings per share (EPS) of $3.36 an increase over its 2021 EPS that were of $2.34.

EPS history for Repligen from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.09-37.8%
2022$3.3643.59%
2021$2.34105.26%
2020$1.14153.33%
2019$0.4518.42%
2018$0.38-47.95%
2017$0.73108.57%
2016$0.3520.69%
2015$0.2916%
2014$0.25-48.98%
2013$0.496.52%
2012$0.46-512.88%
2011-$0.11-1214.13%
2010$0.010000-106.25%
2009-$0.16-200%
2008$0.16-87.79%
2007$1.31-2283.33%
2006-$0.06000-300%
2005$0.03000-115%
2004-$0.20-25.93%
2003-$0.2780%
2002-$0.15-21.05%
2001-$0.19-0%
2000-$0.19-17.39%
1999-$0.23245.01%
1998-$0.0666633.33%
1997-$0.05000-87.18%
1996-$0.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$0.76-480.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$18.99-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$8.73-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$4.52-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-$0.38 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-$1.52 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$7.05-3,625.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$1.17-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-$4.84 2,320.00%๐Ÿ‡บ๐Ÿ‡ธ USA